Actinogen Medical LimitedASX: ACW

Application for quotation of securities - ACW

Sep 22, 2026 at 10:35 PM EDT · Issued by Actinogen Medical Limited via ASX

Filed with ASX · Sep 22, 2026 at 10:35 PM EDT · 6 pages · English

On 6ix: 6ix.com/news/application-for-quotation-of-securities-acw-1

Release

Appendix 2A - Application for quotation of securitiesAppendix 2A - Application for quotation of securities1 / 6Announcement SummaryEntity nameACTINOGEN MEDICAL LIMITEDAnnouncement TypeNew announcementDate of this announcementWednesday September 23, 2026The +securities to be quoted are:Total number...

Actinogen Medical Limited on 6ix

Earlier from Actinogen Medical

ACW Alzheimers pivotal trial completes last patient visitSep 22
Notification of cessation of securities - ACWSep 15
Appendix 3Y-Dr Geoffrey BrookeSep 8
ACW CMO international Xanamem presentationSep 8
Response to ASX Price QuerySep 4

Later from Actinogen Medical

Options underwriting cleansing noticeSep 22
Underwriting of unlisted options completedSep 22
Actinogen XanaMIA pivotal Alzheimer’s disease trial completes final patient visit, with topline results on track for NovemberSep 23
AGM date and closing date for director nominationsOct 8
Notification of buy-back - ACWOct 11

All Actinogen Medical news releases

Follow Actinogen Medical into a list and get an email when it puts out news.

Follow Actinogen Medical